New AstraZeneca guidance reinforces need for vaccine counselling MBS numbers The decision to limit the use of AstraZeneca’s COVID vaccine to only people aged 60 and older will likely place more pressure on GPs dealing with vaccine-hesitant patients.
Could incentives boost vaccine uptake in Australia? Experts say yes, but different approaches are required for different groups.
GPs key to opening up ‘fortress Australia’ The re-opening of international borders is inevitable, but first GPs need help to combat COVID complacency and vaccine hesitancy.
No evidence that recent blood clot deaths were linked to COVID vaccine The TGA has confirmed there is ‘no likely association’ between the deaths of two NSW men and the AstraZeneca vaccine.
Growing number of Australians reject COVID vaccination Vaccine hesitancy has soared since recommendations shifted from AstraZeneca to Pfizer for under-50s.
Fears AstraZeneca pause in Europe could give rise to vaccine hesitancy in Australia At least 13 countries have raised the alarm about possible links between the coronavirus vaccine and blood clots. How will GPs address these concerns with patients?
Boosting vaccine preparedness amid increasing hesitancy New research aims to tackle vaccine hesitancy by enabling transparency and confidence through improved communication strategies.
Addressing vaccine hesitancy in CALD communities From cultural and religious beliefs to mistrusting government – how can GPs best address any concerns during the vaccine rollout?
GP input key to vaccine uptake for more than 60% of Australians General practice will play a leading role in addressing COVID vaccination hesitancy and attempts at ‘vaccine shopping’.